![Kathleen Richton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kathleen Richton
Directeur Financier/CFO chez
ENGENE THERAPEUTICS INC.
Fortune : 12 351 $ au 31/07/2026
Profil
Ms. Kathleen Richton is a Senior VP, Chief Financial & Accounting Officer at enGene Therapeutics, Inc. Ms. Richton was previously employed as a Vice President & Controller by Sunovion Pharmaceuticals, Inc. She received her undergraduate degree from Bentley University and a graduate degree from Bentley University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ENGENE THERAPEUTICS INC. 0,01 % | 16/07/2026 | 6 900 ( 0,01 % ) | 12 351 $ | 31/07/2026 |
Postes actifs de Kathleen Richton
| Sociétés | Poste | Début |
|---|---|---|
| ENGENE THERAPEUTICS INC. | Directeur Financier/CFO | 16/07/2026 |
Anciens postes connus de Kathleen Richton
| Sociétés | Poste | Fin |
|---|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Comptroller/Controller/Auditor | 01/07/2023 |
Formation de Kathleen Richton
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
29
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Bentley University
 Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
enGene Holdings, Inc.
 enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines | Commercial Services |
